Other OTC Pharmaceuticals - Canada

Canada

Highlights

In Canada, the revenue in the Other OTC Pharmaceuticals sector in 2024 is estimated to be US$430.80m.
It is projected to experience an annual growth rate of 1.08% (CAGR 2024-2029).
When compared to other countries worldwide, the United States leads in terms of revenue generation, with US$7.17bn in 2024.
Taking into account the total population figures, the per person revenues in Canada amount to US$11.02 in 2024.
In Canada, the demand for natural and homeopathic remedies in the Other OTC Pharmaceuticals market is steadily increasing.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Canada has been experiencing steady growth in recent years.

Customer preferences: Customers in Canada have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors. Firstly, OTC medications are easily accessible and do not require a prescription, making them convenient for consumers. Additionally, OTC products are often more affordable than prescription medications, which is appealing to cost-conscious consumers. Lastly, the increasing awareness and emphasis on self-care and preventive healthcare have also contributed to the growing demand for OTC pharmaceuticals in Canada.

Trends in the market: One of the key trends in the Other OTC Pharmaceuticals market in Canada is the rising demand for natural and herbal remedies. Consumers are increasingly opting for products that are perceived as more natural and less chemically based. This trend can be attributed to a growing interest in holistic health and wellness. Manufacturers have responded to this trend by introducing a wide range of natural and herbal OTC products, including supplements, vitamins, and homeopathic remedies.Another trend in the market is the increasing availability and popularity of private label OTC products. Private label brands, which are owned and sold by retailers, have gained significant market share in recent years. This can be attributed to their lower price points compared to national brands, as well as the trust that consumers have in the quality and efficacy of private label products. Retailers have been actively expanding their private label OTC product lines to cater to the growing demand.

Local special circumstances: Canada has a unique regulatory environment for OTC pharmaceuticals. The country's healthcare system is publicly funded, and the government plays a significant role in regulating the sale and distribution of healthcare products. Health Canada, the country's regulatory authority, sets strict guidelines for the safety, efficacy, and labeling of OTC products. This ensures that consumers have access to safe and effective medications.

Underlying macroeconomic factors: Several macroeconomic factors have contributed to the growth of the Other OTC Pharmaceuticals market in Canada. Firstly, the country's aging population has led to an increased demand for healthcare products, including OTC medications. As the population ages, there is a greater need for products that address common health issues such as pain relief, digestive health, and sleep disorders.Secondly, the rising healthcare costs in Canada have also played a role in the growth of the OTC pharmaceuticals market. As healthcare expenses continue to rise, consumers are looking for more affordable alternatives to prescription medications. OTC products offer a cost-effective solution for managing common health conditions, which has contributed to their popularity.In conclusion, the Other OTC Pharmaceuticals market in Canada is growing due to customer preferences for accessible and affordable healthcare products, as well as the increasing demand for natural and private label remedies. The unique regulatory environment and underlying macroeconomic factors have also contributed to the market's growth.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.